80 results
S-4MEF
EX-8.1
ENVB
Enveric Biosciences Inc
28 Dec 20
Addition of securities to prior registration
5:30pm
(without any independent investigation or review of any factual statements therein) the truth and accuracy, at all relevant times, of the statements … as we have deemed necessary or appropriate.
In connection with rendering this opinion, we have assumed (without any independent investigation or review
8-K
EX-10.2
d0mli 2bxg3
4 Jun 20
Ameri Holdings Amalgamation Partner Jay Pharma Reports Irb Approval for Testing Proprietary CBD Formulation In Brain Cancer
9:00am
8-K
EX-10.1
pw7pw phmh42
11 Sep 20
Entry into a Material Definitive Agreement
8:00am
8-K
EX-10.5
85ih4tfkba z6k
25 Jan 19
Entry into a Material Definitive Agreement
3:55pm
8-K
EX-1.1
irtov4i
1 Sep 23
Entry into a Material Definitive Agreement
5:26pm
8-K
EX-10.2
e24ua
26 Jul 22
Enveric Biosciences Announces $8 Million Registered Direct Offering and Private Placement, Priced at a Premium to Market Under Nasdaq Rules
5:15pm
8-K
EX-1.1
yoyywex
15 Feb 22
Enveric Biosciences Announces Proposed Public Offering
11:07am
8-K
EX-10.1
0cidll7ltma97hkdi4
26 Jul 22
Enveric Biosciences Announces $8 Million Registered Direct Offering and Private Placement, Priced at a Premium to Market Under Nasdaq Rules
5:15pm
8-K
EX-10.2
ejjuz8meig1dy
6 Nov 23
Entry into a Material Definitive Agreement
8:05am
8-K
EX-10.1
613i8 ik9fb8
11 Feb 21
Enveric Biosciences Inc. Announces $12.8 Million Registered Direct Offering
4:01pm
8-K
EX-10.1
l124os8aoe
4 Jun 20
Ameri Holdings Amalgamation Partner Jay Pharma Reports Irb Approval for Testing Proprietary CBD Formulation In Brain Cancer
9:00am
8-K
EX-10.1
dfs jg8tl7qjese
12 Jan 21
Enveric Biosciences Inc. Announces $10 Million Registered Direct Offering
9:10am